LFMD
LifeMD, Inc.
Overview
LifeMD provides virtual medical care and pharmacy services through a vertically integrated platform combining affiliated providers, proprietary technology, and a wholly-owned pharmacy.
LifeMD, Inc is a Healthcare company operating in Health Information Services with a $229.7M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0610 Q&A exchanges
- Q4 FY2025Earnings2026-03-0913 Q&A exchanges
- Q3 FY2025Earnings2025-11-1715 Q&A exchanges
- Q2 FY2025Earnings2025-08-0515 Q&A exchanges
- Q1 FY2025Earnings2025-05-0618 Q&A exchanges
- Q4 FY2024Earnings2025-03-1020 Q&A exchanges
- Q3 FY2024Earnings2024-11-0916 Q&A exchanges
- Q2 FY2024Earnings2024-08-0822 Q&A exchanges
- Q1 FY2024Earnings2024-05-0810 Q&A exchanges
- Q4 FY2023Earnings2024-03-1120 Q&A exchanges
- Q3 FY2023Earnings2023-11-0817 Q&A exchanges
- Q2 FY2023Earnings2023-08-0920 Q&A exchanges
- Q1 FY2023Earnings2023-05-1210 Q&A exchanges
- Q4 FY2022Earnings2023-03-2212 Q&A exchanges
- Q3 FY2022Earnings2022-11-1014 Q&A exchanges
- Q2 FY2022Earnings2022-08-1111 Q&A exchanges
- Q1 FY2022Earnings2022-05-1314 Q&A exchanges
- Q4 FY2021Earnings2022-03-0715 Q&A exchanges
- Q3 FY2021Earnings2021-11-1011 Q&A exchanges
- Q2 FY2021Earnings2021-08-129 Q&A exchanges
- Q1 FY2021Earnings2021-05-1316 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $-0.20—Rev— vs ——EODHD
- Q1 FY20262026-05-07EPS$-0.15 vs $-0.12-29.9%Rev$50.2M vs ——EODHD
- Q4 FY20252026-03-15EPS$0.06 vs $-0.07+100.0%Rev$46.9M vs ——EODHD
- Q3 FY20252025-11-16EPS$-0.10 vs $-0.04-100.0%Rev$60.2M vs ——EODHD
- Q2 FY20252025-08-04EPS$-0.06 vs $-0.02-100.0%Rev$62.2M vs ——EODHD
- Q1 FY20252025-05-05EPS$0.03 vs $0.14-79.9%Rev$65.7M vs ——EODHD
- Q4 FY20242025-03-09EPS$0.21 vs $0.14+50.0%Rev$64.3M vs ——EODHD
- Q3 FY20242024-11-06EPS$-0.14 vs $-0.12-16.7%Rev$53.3M vs ——EODHD
- Q2 FY20242024-08-06EPS$-0.19 vs $-0.12-58.3%Rev$50.7M vs ——EODHD
- Q1 FY20242024-05-07EPS$-0.19 vs $-0.15-26.7%Rev$44.1M vs ——EODHD
- Q4 FY20232024-03-10EPS$-0.12 vs $-0.14+14.3%Rev$44.9M vs ——EODHD
- Q3 FY20232023-11-07EPS$-0.20 vs $-0.15-33.3%Rev$38.6M vs ——EODHD
- Q2 FY20232023-08-08EPS$-0.23 vs $-0.10-100.0%Rev$35.9M vs ——EODHD
- Q1 FY20232023-05-11EPS$-0.15 vs $-0.16+6.3%Rev$33.1M vs ——EODHD
- Q4 FY20222023-03-21EPS$-0.40 vs $-0.18-100.0%Rev$28.1M vs ——EODHD
- Q3 FY20222022-11-09EPS$-0.26 vs $-0.28+7.1%Rev$31.4M vs ——EODHD
- Q2 FY20222022-08-10EPS$-0.45 vs $-0.35-28.6%Rev$30.5M vs ——EODHD
- Q1 FY20222022-05-12EPS$-0.46 vs $-0.36-27.8%Rev$29.0M vs ——EODHD
- Q4 FY20212022-03-06EPS$-0.62 vs $-0.42-47.6%Rev$27.4M vs ——EODHD
- Q3 FY20212021-11-09EPS$-0.54 vs $-0.62+12.9%Rev$24.9M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $-0.20 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-07 | $-0.15 | $-0.12 | -29.9% | $50.2M | — | — | EODHD |
| Q4 FY2025 | 2026-03-15 | $0.06 | $-0.07 | +100.0% | $46.9M | — | — | EODHD |
| Q3 FY2025 | 2025-11-16 | $-0.10 | $-0.04 | -100.0% | $60.2M | — | — | EODHD |
| Q2 FY2025 | 2025-08-04 | $-0.06 | $-0.02 | -100.0% | $62.2M | — | — | EODHD |
| Q1 FY2025 | 2025-05-05 | $0.03 | $0.14 | -79.9% | $65.7M | — | — | EODHD |
| Q4 FY2024 | 2025-03-09 | $0.21 | $0.14 | +50.0% | $64.3M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.14 | $-0.12 | -16.7% | $53.3M | — | — | EODHD |
| Q2 FY2024 | 2024-08-06 | $-0.19 | $-0.12 | -58.3% | $50.7M | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $-0.19 | $-0.15 | -26.7% | $44.1M | — | — | EODHD |
| Q4 FY2023 | 2024-03-10 | $-0.12 | $-0.14 | +14.3% | $44.9M | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $-0.20 | $-0.15 | -33.3% | $38.6M | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $-0.23 | $-0.10 | -100.0% | $35.9M | — | — | EODHD |
| Q1 FY2023 | 2023-05-11 | $-0.15 | $-0.16 | +6.3% | $33.1M | — | — | EODHD |
| Q4 FY2022 | 2023-03-21 | $-0.40 | $-0.18 | -100.0% | $28.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.26 | $-0.28 | +7.1% | $31.4M | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-0.45 | $-0.35 | -28.6% | $30.5M | — | — | EODHD |
| Q1 FY2022 | 2022-05-12 | $-0.46 | $-0.36 | -27.8% | $29.0M | — | — | EODHD |
| Q4 FY2021 | 2022-03-06 | $-0.62 | $-0.42 | -47.6% | $27.4M | — | — | EODHD |
| Q3 FY2021 | 2021-11-09 | $-0.54 | $-0.62 | +12.9% | $24.9M | — | — | EODHD |
Source: EODHD. LFMD reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks LFMD's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 90% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.56 | $2.14 | +19.6% | +0.8% | -0.3% |
| Q4 FY2026 | $2.63 | $2.05 | +28.3% | +6.9% | +9.0% |
| Q3 FY2026 | $2.56 | $2.05 | +25.0% | +2.8% | +1.5% |
| Q2 FY2026 | $2.96 | $2.29 | +29.1% | +3.7% | +1.6% |
| Q1 FY2025 | $2.40 | $2.03 | +18.1% | +6.3% | +4.2% |
| Q4 FY2025 | $2.91 | $2.26 | +28.9% | +1.2% | +3.0% |
| Q3 FY2025 | $2.75 | $2.12 | +29.6% | -2.4% | -4.8% |
| Q2 FY2025 | $2.50 | $2.10 | +18.9% | +0.1% | -2.5% |
| Q1 FY2024 | $2.66 | $2.22 | +19.6% | +7.4% | +7.6% |
| Q4 FY2024 | $2.96 | $2.31 | +28.1% | +7.2% | +7.8% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Justin SchreiberCEO1 yr 3 mo21 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • guidance suspended Q2 FY2026
- Atul KavthekarCFO3 mono recorded callsCurrentSample
CFO since 2026 • 1/2 beats (50%) • last call held guidance Q1 FY2026
- Marc David BenathenCFO1 yr 3 mono recorded callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance cut Q2 FY2026
- Shayna Webb DrayCOO11 mono recorded callsCurrentSample
COO since 2025 • 2/4 beats (50%) • last guidance raise Q3 FY2026
- Christopher A PisanoChief Marketing Officer3 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last call held guidance Q3 FY2026
- Dennis WijnkerChief Technology Officer1 yr 3 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LFMD.
$ curl https://api.spokenalpha.com/v1/companies/LFMDFAQ
Frequently asked about LFMD
Where can I find LifeMD, Inc.'s (LFMD) earnings call transcripts?
Spoken Alpha indexes LFMD's earnings call transcripts at https://spokenalpha.com/companies/LFMD. Each call links to attributed speakers and parsed analyst Q&A. LifeMD, Inc.'s own investor relations page is at https://ir.lifemd.com/.
When was LifeMD, Inc.'s most recent earnings call?
LifeMD, Inc. (LFMD) held its most recent earnings call on 2026-05-06, covering fiscal Q1 2026.
What sector is LFMD in?
LifeMD, Inc. (LFMD) operates in the Healthcare sector (Health Information Services industry).